Trinity Biotech PLC ADR TRIB
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRIB is a good fit for your portfolio.
News
-
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
-
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
-
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
-
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
-
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
-
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
-
Trinity Biotech to Present at Emerging Growth Conference
-
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
Trading Information
- Previous Close Price
- $1.83
- Day Range
- $1.78–1.97
- 52-Week Range
- $1.78–5.50
- Bid/Ask
- $1.78 / $1.88
- Market Cap
- $13.60 Mil
- Volume/Avg
- 10,525 / 22,345
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.06
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 398
- Website
- https://www.trinitybiotech.com
Valuation
|
Metric
|
TRIB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.06 |
Price/Cash Flow | — |
Price/Earnings
TRIB
Financial Strength
|
Metric
|
TRIB
|
|---|---|
Quick Ratio | 1.80 |
Current Ratio | 3.44 |
Interest Coverage | −2.61 |
Quick Ratio
TRIB
Profitability
|
Metric
|
TRIB
|
|---|---|
Return on Assets (Normalized) | −25.46% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −17.03% |
Return on Assets
TRIB
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Hblsgddt | Zhkh | $220.2 Bil | |
DHR
| Danaher Corp | Xsvncynlp | Rhdtdk | $182.8 Bil | |
IQV
| IQVIA Holdings Inc | Lzxqgrxgw | Nfhkmtn | $42.9 Bil | |
IDXX
| IDEXX Laboratories Inc | Qvllbjlfj | Qktvgz | $42.0 Bil | |
A
| Agilent Technologies Inc | Mxvzvmwrr | Flgp | $40.9 Bil | |
MTD
| Mettler-Toledo International Inc | Nfndsdgwn | Kvjvtsx | $26.8 Bil | |
ICLR
| Icon PLC | Kmgmlngt | Xxqtfy | $25.1 Bil | |
ILMN
| Illumina Inc | Rbnxylzvd | Xttzjpn | $19.9 Bil | |
WAT
| Waters Corp | Gxrjgwng | Mmjx | $18.7 Bil | |
LH
| Laboratory Corp of America Holdings | Hwydpwtjl | Kfsycd | $17.2 Bil |